FIELD: medicine.
SUBSTANCE: method involves injecting membrane-associated antigen vaccine from destroyed tumor cells. Biopsy tumor cells taken from patient are used as raw vaccine material. Vaccine is produced by irradiating cell suspension with pulsating electric field having succession frequency and rectangular pulse duration equal to 35-50 Hz and 5-7 ms, respectively, specific current amplitude being equal to 300-500 mcA during 30-40 min in microelements presence. The injection is carried out by subcutaneously implanting incubator-carriers manufactured from porous titanium nickelide having vaccine deposited into the pores.
EFFECT: enhanced effectiveness of oncologic disease treatment.
3 cl
| Title | Year | Author | Number |
|---|---|---|---|
| DEVICE FOR CARRYING CELLULAR CULTURES OF ARTIFICIAL VISCERAL ORGANS | 2000 |
|
RU2191607C2 |
| METHOD FOR TREATING PATIENTS FOR DIABETIC LOW EXTREMITY GANGRENE | 2003 |
|
RU2261049C2 |
| CANCER IMMUNOREHABILITAITON MODE | 2008 |
|
RU2377994C1 |
| REGULATOR OF CELLULAR GROWTH IN VITRO AND METHOD FOR CELLULAR GROWTH REGULATION IN VITRO | 2000 |
|
RU2179578C2 |
| MIXTURE FOR PRODUCTION OF CELLULAR STRUCTURE CARRIER | 1999 |
|
RU2170645C2 |
| METHOD OF PRODUCING VACCINE FOR TREATMENT OF ERLICH'S ADENOCARCINOMA IN EXPERIMENT | 2009 |
|
RU2438699C2 |
| METHOD OF TREATING DISSEMINATED AND LOCALLY-SPREAD IV STAGE STOMACH CANCER | 2007 |
|
RU2370222C2 |
| IMPLANT FOR SURGICAL TREATMENT OF INTERNAL ORGAN DISEASES | 1997 |
|
RU2143867C1 |
| IN VITRO METHOD FOR TREATING CELLS | 2005 |
|
RU2290219C2 |
| METHOD AND DEVICE FOR SURGERY OF SOLITARY NEOPLASMS OF PARENCHYMAL ORGANS | 2008 |
|
RU2380050C1 |
